Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BCTX trades at $3.98 with a market cap of $24.29M and a P/E ratio of -0.06. BCTX moved +9.69% today. Year to date, BCTX is -49.28%; over the trailing twelve months it is -89.10%. Its 52-week range spans $2.98 to $214.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded BCTX stock?
Rallies tracks politician and congressional stock disclosures for BCTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Lustig Marc bought 902.93K (~$2.00M) on May 14, 2024.
Bondarenko Jamieson bought 28.00K (~$128.24K) on Dec 28, 2022.
Bondarenko Jamieson bought 22.00K (~$117.70K) on Dec 20, 2022.
BCTX Analyst Consensus
BCTX analyst coverage data. Average price target: $0.00.
Common questions about BCTX
Which politicians traded BCTX stock?
Rallies tracks politician and congressional stock disclosures for BCTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BCTX?
Yes. Rallies tracks politician and congressional stock disclosures for BCTX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BCTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BCTX. It does not provide personalized investment advice.
